Search

everythinglearnresearchcommunity

for

Search:↓

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

FUE effectively corrects poorly designed hairlines in men with androgenetic alopecia.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

miRNAs in the Dlk1-Gtl2 region may improve lamb fur quality.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

The Hr protein binds to DNA, interacts with p53, and affects cell cycle genes.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.